1,4,7-Trihydroxy-2-methoxy-6-methylanthracene-9,10-dione

Details

Top
Internal ID bdff413b-d983-4668-ab80-a94c20d5e2fd
Taxonomy Benzenoids > Anthracenes > Anthraquinones > Hydroxyanthraquinones
IUPAC Name 1,4,7-trihydroxy-2-methoxy-6-methylanthracene-9,10-dione
SMILES (Canonical) CC1=CC2=C(C=C1O)C(=O)C3=C(C2=O)C(=CC(=C3O)OC)O
SMILES (Isomeric) CC1=CC2=C(C=C1O)C(=O)C3=C(C2=O)C(=CC(=C3O)OC)O
InChI InChI=1S/C16H12O6/c1-6-3-7-8(4-9(6)17)15(20)13-12(14(7)19)10(18)5-11(22-2)16(13)21/h3-5,17-18,21H,1-2H3
InChI Key HUFZYYGFQYHTGV-UHFFFAOYSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C16H12O6
Molecular Weight 300.26 g/mol
Exact Mass 300.06338810 g/mol
Topological Polar Surface Area (TPSA) 104.00 Ų
XlogP 3.20
Atomic LogP (AlogP) 1.90
H-Bond Acceptor 6
H-Bond Donor 3
Rotatable Bonds 1

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of 1,4,7-Trihydroxy-2-methoxy-6-methylanthracene-9,10-dione

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9867 98.67%
Caco-2 + 0.6383 63.83%
Blood Brain Barrier - 0.7750 77.50%
Human oral bioavailability + 0.7714 77.14%
Subcellular localzation Mitochondria 0.8309 83.09%
OATP2B1 inhibitior - 0.7028 70.28%
OATP1B1 inhibitior + 0.9057 90.57%
OATP1B3 inhibitior + 0.9329 93.29%
MATE1 inhibitior - 0.9400 94.00%
OCT2 inhibitior - 1.0000 100.00%
BSEP inhibitior - 0.7512 75.12%
P-glycoprotein inhibitior - 0.8538 85.38%
P-glycoprotein substrate - 0.9316 93.16%
CYP3A4 substrate - 0.5247 52.47%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.7976 79.76%
CYP3A4 inhibition - 0.8346 83.46%
CYP2C9 inhibition + 0.5067 50.67%
CYP2C19 inhibition - 0.6468 64.68%
CYP2D6 inhibition - 0.7472 74.72%
CYP1A2 inhibition + 0.9109 91.09%
CYP2C8 inhibition - 0.7553 75.53%
CYP inhibitory promiscuity - 0.6522 65.22%
UGT catelyzed - 0.5000 50.00%
Carcinogenicity (binary) - 0.8795 87.95%
Carcinogenicity (trinary) Non-required 0.5355 53.55%
Eye corrosion - 0.9806 98.06%
Eye irritation + 0.8774 87.74%
Skin irritation - 0.5600 56.00%
Skin corrosion - 0.9405 94.05%
Ames mutagenesis + 0.5300 53.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7059 70.59%
Micronuclear + 0.8300 83.00%
Hepatotoxicity + 0.5982 59.82%
skin sensitisation - 0.8987 89.87%
Respiratory toxicity - 0.6222 62.22%
Reproductive toxicity + 0.6222 62.22%
Mitochondrial toxicity + 0.5125 51.25%
Nephrotoxicity + 0.5261 52.61%
Acute Oral Toxicity (c) II 0.5323 53.23%
Estrogen receptor binding + 0.7722 77.22%
Androgen receptor binding + 0.5317 53.17%
Thyroid receptor binding - 0.5736 57.36%
Glucocorticoid receptor binding + 0.8807 88.07%
Aromatase binding + 0.6067 60.67%
PPAR gamma + 0.6342 63.42%
Honey bee toxicity - 0.9097 90.97%
Biodegradation - 0.8500 85.00%
Crustacea aquatic toxicity - 0.6400 64.00%
Fish aquatic toxicity + 0.9767 97.67%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 95.63% 91.11%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 95.55% 95.56%
CHEMBL2581 P07339 Cathepsin D 91.71% 98.95%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 90.17% 94.00%
CHEMBL1860 P10827 Thyroid hormone receptor alpha 88.08% 99.15%
CHEMBL1293249 Q13887 Kruppel-like factor 5 86.61% 86.33%
CHEMBL1806 P11388 DNA topoisomerase II alpha 86.53% 89.00%
CHEMBL4208 P20618 Proteasome component C5 84.12% 90.00%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 84.00% 85.14%
CHEMBL3194 P02766 Transthyretin 83.07% 90.71%
CHEMBL3401 O75469 Pregnane X receptor 82.85% 94.73%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 82.35% 99.23%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 81.33% 96.00%
CHEMBL2041 P07949 Tyrosine-protein kinase receptor RET 80.45% 91.79%

Cross-Links

Top
PubChem 54752971
NPASS NPC167240
LOTUS LTS0052433
wikiData Q105033758